Increased Use of Symptom-Relieving Dementia Drugs (Acetylcholinesterase Inhibitors) for People With Alzheimer's Disease (or Proportion of Patients With Alzheimer's Disease Who Receive Symptom-Relieving Antidementia Drugs)

Identifying Attributes

Care Settings

Dementia Care

Country

Sweden

Publishing Organisation

Swedish Behavioral and Psychological Symptoms of Dementia (BPSD) Register

Type of Quality Indicator

Process

IOM Quality Dimension

Effectiveness

Domain

Interventions to Promote Cognition, Independence and Wellbeing

Defining Attributes

Definition

Proportion of people with Alzheimer's disease who receive symptom-relieving antidementia drugs

Numerator

Number of patients with Alzheimer's disease who receive symptom-relieving antidementia drugs

Denominator

Number of patients with Alzheimer's disease

Exclusions

Use of Risk Adjustment

Risk Adjustments

Stratifications

County/municipality/district

Data Attributes

Type of Data Collection

Standardised clinical data

Data Collection Methods

Data entered by participating sites into a secure online platform

Frequency of Data Collection

Continuous

Frequency of Data Collection in Days

Reporting Methods

Online at pharos.skane.se/bpsddataportal/, and annual reports

Reporting Frequency

Annually & real time (online public portal)

Reporting Frequency in Days

1-365

Indicator Has Recommended Targets

Yes

Source and Reference Attributes

Evidence Source

2022 Annual report downloaded from bpsd.se/styrgruppen/ (in swedish) Strohmaier C and Gassner L. Quality Registries in Dementia Care: Mapping of Registries to improve Quality and Service Delivery. AIHTA Project Report No.: 150; 2022. Vienna: HTA Austria – Austrian Institute for Health Technology Assessment GmbH.

Technical Specifications

Link to Measurement Tools

Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022

Yes